MemoHoney Official Website › MemoHoney Disclaimer
MemoHoney DisclaimerThe MemoHoney Disclaimer: Every Standing Statement, In One Place
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease. It is a dietary supplement rather than a drug and it is not FDA-approved. The rest of this page sets out the other standing statements that govern what this website says.
Gathered here so that each one can be stated once, properly, rather than repeated in fragments across thirty pages.
The MemoHoney FDA statement
The statement at the top of this page is the one required of every dietary supplement sold in the United States, and it appears in the footer of every page on this website.
What it means in practice: the FDA does not review or approve dietary supplements before they go on sale. A manufacturer is responsible for the safety of what it sells and for the truthfulness of what it claims, and the agency acts afterwards if something is wrong. The FDA-facility emblem on this product refers to a registration that every US food facility files, and a registration is not an approval.
The FDA publishes a question-and-answer page on dietary supplements which is worth ten minutes of anybody's time before buying anything in this category.
The MemoHoney medical disclaimer
Nothing on this website is medical advice and nothing here is a substitute for an assessment. The pages describe a product, quote a label and set published trials beside ingredient names. That is information, not a consultation.
Memory that is changing in a way you or the people around you notice, that is getting worse month on month, or that is interfering with work or with familiar routes, belongs in a consulting room. That is true whatever is on this shelf and it is the one thing this website would put above every other sentence on it.
Four of the seven lines on this label feed the nitric oxide pathway, which is the pathway nitrates, blood-pressure medicines and erectile-dysfunction drugs act on. Raise it with whoever prescribes for you before starting. The interaction page sets out the detail.
The MemoHoney results disclaimer
People differ and so do outcomes. Sleep, hearing, blood pressure, activity and diet all act on the thing this capsule is sold for, and several of them have randomised evidence behind them that it does not.
The distributor's own figure for when its buyers notice anything is 3–6 weeks. That is a statement about a group of buyers rather than a prediction about any individual, and no trial of this product exists to make a prediction from.
Nothing here promises a result. What the seller promises is a money-back window, which is a promise about money.
The MemoHoney label and amounts statement
The Supplement Facts panel on the bottle, as the seller's own page shows it, prints seven active lines per one-capsule serving: L-Arginine (base) 200 mg, L-Arginine AKG 2:1 Extract 200 mg, L-Citrulline HCl 100 mg, L-Citrulline Malate 100 mg, Beta Alanine 40 mg, Niacin 7.5 mg NE and Calcium (as calcium carbonate) 18 mg. Other ingredients: hypromellose (vegetable capsule), vegetable stearate, silicon dioxide. The seller's advertising names 6 of the seven, and where the two differ this website follows the label.
Every other amount printed on this website belongs to a published trial and is attributed to that trial, with its population and its outcome attached. No figure for anything in this bottle is estimated, inferred or implied. The comparison is made in one place.
The panel was read on 21 September 2026. If the bottle you receive prints something different, the bottle wins; tell this desk and the pages change the same week.
The MemoHoney review and figures statement
The star score of 4.6, the 1,354 written reviews, the 9,027 orders and the 92% recommendation rate are the distributor's own figures about its own sales, and its reviews are its own unverified testimonials. They are not audited transcripts and this counter cannot verify them.
Eight named reviewers appear against two bodies of text, which is summary copy. No review or rating markup of any kind is emitted anywhere on this website, because doing so would state in machine-readable form something this desk cannot stand behind.
Lot MEM-26/ME-4192 and certificate reference MEM-4192-26-ME identify a production run and a filing. Neither is a laboratory result and this counter has not been supplied with the underlying document.
The MemoHoney commercial statement
This website sells the product it writes about. Memohoeney is a USA authorized retailer and earns from orders placed through this counter. That is stated in the masthead of every page rather than buried in a footnote.
Every price on this site was read off the seller's own page on 20 September 2026 and is printed with that date attached. The figure the checkout shows at the moment of payment is the one that binds. Where a second, higher number appears with a line through it, that is the seller's own comparison mark and nobody was charged it; the same goes for the value attached to each bonus download.
The standing sources behind this MemoHoney disclaimer
- Questions and Answers on Dietary Supplements. U.S. Food and Drug Administration. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- Using Dietary Supplements Wisely. National Center for Complementary and Integrative Health, National Institutes of Health. https://www.nccih.nih.gov/health/using-dietary-supplements-wisely
- Memory. MedlinePlus, U.S. National Library of Medicine. https://medlineplus.gov/memory.html
- Niacin: Fact Sheet for Health Professionals. Office of Dietary Supplements, National Institutes of Health. https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/
- Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023;402(10404):786-797. PMID 37478886. https://pubmed.ncbi.nlm.nih.gov/37478886/
- Williamson JD, Pajewski NM, Auchus AP, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553-561. PMID 30688979. https://pubmed.ncbi.nlm.nih.gov/30688979/
Order MemoHoney with every standing statement read
A dietary supplement, not a drug. One capsule a morning, 30 to a bottle, and 60 days from the date of purchase.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order MemoHoney From This CounterLot MEM-26/ME-4192 · one a morning, 30 to a bottle · ships from the United States
